Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

High-Risk Resectable NSCLC × pembrolizumab × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 76 Melanoma 35 Parkinson Disease 4, Autosomal Dominant Lewy Body 33 Lung Neoplasms 33 Squamous Cell Carcinoma of Head and Neck 29 Triple Negative Breast Neoplasms 23 Neoplasms 22 Colorectal Neoplasms 21 Breast Neoplasms 21 Neoplasm Metastasis 18 Ovarian Neoplasms 16 Carcinoma, Transitional Cell 16 Stomach Neoplasms 14 Endometrial Neoplasms 14 Carcinoma, Renal Cell 14 Urinary Bladder Neoplasms 12 Esophageal Neoplasms 12 Carcinoma 12 Uterine Cervical Neoplasms 11 Pancreatic Neoplasms 10 Recurrence 7 Esophageal Squamous Cell Carcinoma 7 Head and Neck Neoplasms 6 Carcinoma, Hepatocellular 6 Small Cell Lung Carcinoma 5 Mouth Neoplasms 5 Lymphoma 5 Laryngeal Neoplasms 5 Glioblastoma 5 Colonic Neoplasms 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡